Are you qualifying your suppliers?

A company recently received this 483 observation:

….. The program for evaluating and monitoring supplies of raw materials is not adequate.

 Specifically,

a.              Your firm has not conducted vendor qualification for the supplier of raw materials used in the manufacturing of … API.

b.             Your firm’s Production Manager stated … was manufactured at the firm until several years ago.  QC/QA Manager stated that after this date the firm purchased … from an outside vendor and shipped to different markets including the United States by relabeling under the name of their firm. QA/ Manager and Production Manager stated that the … purchased from a new vendor is not qualified and not approved by the firm. Your firm has no procedure for supplier qualification.

For more observations pertaining to API controls, see Issue 1047 available today.  It also has observations pertaining to lab controls, manufacturing controls, and medical devices.

Stay in Compliance! Subscribe today!

Stay in Compliance!

To get the most out of GMP Trends®, sign up to one of our subscription packages for valuable, up-to-date information you won't find anywhere else!

LEARN MORE
About GMP Trends

GMP TRENDS is a publication for the pharmaceutical and medical device industries, trending observations made by FDA investigators during GMP inspections throughout the world.

Available Reports
Stay in Compliance!

Sign up for free highlights and updates from GMP Trends


Report Categories
Recent Posts
Recent Comments
Archives
Categories
Meta

Become A Subscriber And Stay Ahead of the FDA

To get the most out of GMP Trends®, sign up to one of our subscription packages for valuable, up-to-date information you won't find anywhere else! Every subscription provides the most frequently cited FDA 483 observations taken from recent FDA Inspections. The non-essential information is redacted to streamline the facts in an easily readable format. Join the thousands of professionals who rely on GMP Trends® to keep them informed of the latest FDA Enforcement Trends!

SUBSCRIBE NOW